Koshinski Asset Management
MRNA icon

Koshinski Asset Management’s Moderna MRNA Stock Holding History

Koshinski Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,185
Closed -$213K – 600
2022
Q4 		$213K Buy
+1,185
New +$194K 0.02% 556
2022
Q2 		– Sell
-709
Closed -$122K – 1454
2022
Q1 		$122K Sell
709
-783
-52% -$132K 0.01% 757
2021
Q4 		$379K Sell
1,492
-924
-38% -$270K 0.03% 463
2021
Q3 		$930K Buy
2,416
+1,076
+80% +$397K 0.08% 273
2021
Q2 		$315K Sell
1,340
-391
-23% -$69.9K 0.04% 420
2021
Q1 		$227K Sell
1,731
-1,586
-48% -$230K 0.02% 533
2020
Q4 		$347K Sell
3,317
-622
-16% -$62.9K 0.04% 401
2020
Q3 		$297 Buy
+3,939
New +$275K 0.04% 393
2020
Q2 		– Sell
-8,210
Closed -$246K – 501
2020
Q1 		$246K Buy
+8,210
New +$189K 0.05% 386

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Koshinski Asset Management's MRNA Position: Q1 2023 in Review

Koshinski Asset Management sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,185 shares — an estimated $213K sold.

Koshinski Asset Management first reported a position in MRNA in Q1 2020 and held it in 9 quarters. The position peaked at $930K in Q3 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Koshinski Asset Management reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Koshinski Asset Management sold 1,185 Moderna shares in Q1 2023, an estimated $213K.
  • Koshinski Asset Management first reported a position in Moderna in Q1 2020 and held it in 9 quarters.
  • Koshinski Asset Management's Moderna position peaked at $930K in Q3 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Koshinski Asset Management's 13F filing for Q1 2023, filed 12 Apr 2023.